+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioactive Coating Devices Market - Global Forecast 2026-2032- Product Image
Bioactive Coating Devices Market - Global Forecast 2026-2032- Product Image
Sale

Bioactive Coating Devices Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011335
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioactive Coating Devices Market is projected to reach USD 2.10 Billion in 2026. It is expected to continue growing at a CAGR of 8.74%, reaching USD 3.47 Billion by 2032.

The bioactive coating devices market is gaining strategic importance as healthcare systems prioritize implant longevity, infection prevention, faster healing, and improved device-tissue integration. Bioactive coatings are engineered surface layers applied to medical devices such as orthopedic implants, cardiovascular stents, dental implants, catheters, wound care products, and surgical instruments to deliver antimicrobial, osteoconductive, hemocompatible, anti-thrombogenic, or drug-eluting performance.

Demand is supported by the global burden of healthcare-associated infections, antimicrobial resistance, diabetes, cardiovascular disease, musculoskeletal disorders, and chronic wounds requiring long-term implanted or minimally invasive devices. Verified public-health evidence, including CDC reporting that roughly 1 in 31 U.S. hospital patients has at least one healthcare-associated infection on any given day and the Lancet estimate that bacterial antimicrobial resistance was directly responsible for 1.27 million deaths in 2019, reinforces the clinical need for coatings that reduce microbial adhesion, biofilm formation, inflammation, thrombosis, and device failure.

For manufacturers, the bioactive coating devices market is defined by convergence across biomaterials science, nanotechnology, additive manufacturing, regulatory compliance, and value-based healthcare. Companies that demonstrate biocompatibility under ISO 10993 principles, scalable manufacturing controls, sterilization compatibility, and measurable clinical outcomes are best positioned to capture demand across hospitals, ambulatory surgery centers, dental clinics, wound care centers, and specialty care settings.

Transformative Shifts in the Bioactive Coating Devices Landscape

The competitive landscape is shifting from passive surface protection toward multifunctional, evidence-driven bioactive coating platforms. Traditional coatings focused on lubricity, corrosion resistance, or basic barrier protection; newer systems integrate antimicrobial agents, hydroxyapatite, silver, titanium oxide, nitric oxide release, heparin, peptides, polymers, ceramics, and drug-eluting matrices to improve clinical performance across high-risk device categories.

Regulatory expectations are also reshaping product development. The U.S. FDA, EU Medical Device Regulation, ISO 13485 quality management requirements, ISO 10993 biological evaluation principles, and international risk management practices emphasize process validation, chemical characterization, post-market surveillance, and real-world safety evidence. This is pushing device makers to invest earlier in coating characterization, sterilization compatibility, shelf-life stability, extractables and leachables testing, particulate assessment, and reproducible deposition technologies.

Another transformative shift is the rise of personalized and procedure-specific coating design. As 3D-printed implants, minimally invasive cardiovascular devices, dental implant systems, antimicrobial catheters, and advanced wound care platforms expand, manufacturers are moving toward coatings tailored by anatomical site, patient risk profile, infection burden, drug-release requirement, and mechanical loading conditions.

Cumulative Impact of Artificial Intelligence on Bioactive Coating Devices

Artificial intelligence is becoming a practical accelerator for the bioactive coating devices market by improving material discovery, process optimization, quality inspection, and clinical evidence generation. Machine learning models can screen polymer blends, antimicrobial combinations, surface topographies, bioactive ceramics, and drug-release profiles faster than conventional trial-and-error methods, helping R&D teams reduce development cycles while improving reproducibility.

AI-enabled imaging and analytics also support coating uniformity assessment, defect detection, surface roughness evaluation, adhesion analysis, and predictive failure assessment. In manufacturing, AI can monitor parameters such as plasma spray conditions, dip-coating viscosity, curing temperature, deposition thickness, surface activation, drying profiles, and sterilization impact to reduce variation and support quality-by-design.

In clinical and commercial settings, AI can connect real-world evidence from electronic health records, device registries, infection surveillance, imaging data, and claims datasets to evaluate outcomes such as revision rates, catheter-associated infections, thrombosis, wound healing, implant integration, and hospital readmissions. This strengthens value-based selling and supports regulatory submissions where transparent, validated, and bias-controlled analytics are used responsibly.

Key Regional Insights Across Bioactive Coating Device Markets

Asia-Pacific is emerging as a high-priority region for bioactive coating devices due to expanding surgical volumes, rising healthcare expenditure, aging populations, and strong medtech manufacturing capabilities across China, Japan, South Korea, India, Singapore, and Australia. Government-backed healthcare modernization, domestic medical device policies, and growing demand for orthopedic implants, dental implants, cardiovascular devices, catheters, and wound care products are encouraging coating localization, cost-efficient supply chains, and partnerships between hospitals, universities, and device manufacturers.

North America remains a leading innovation and commercialization hub, supported by advanced hospital infrastructure, FDA-regulated device pathways, established infection-prevention programs, high adoption of minimally invasive procedures, and strong demand for infection-resistant catheters, drug-eluting cardiovascular devices, coated orthopedic implants, and dental technologies. Europe is shaped by stringent EU MDR requirements, mature clinical research networks, strong biomaterials expertise, and an emphasis on post-market clinical follow-up, with Germany, France, Italy, Spain, the United Kingdom, and Nordic healthcare systems influencing adoption standards.

Latin America is gaining traction through rising procedure volumes and expanding private healthcare capacity in Brazil and Mexico, although reimbursement variability, procurement constraints, and import dependence influence adoption speed. The Middle East is investing in advanced hospitals, specialty surgery, and medical tourism, especially across GCC economies, creating demand for premium coated implants and infection-prevention devices. Africa remains earlier in adoption, with opportunities tied to healthcare-associated infection control, public procurement, surgical access, local distribution partnerships, and affordable coated devices suited to high-burden care settings.

Key Group Insights for Bioactive Coating Devices

ASEAN markets are benefiting from expanding hospital networks, medical tourism, public and private healthcare investment, and regional manufacturing incentives, with Singapore, Malaysia, Thailand, Vietnam, Indonesia, and the Philippines offering varied entry points for coated dental devices, wound care products, catheters, and surgical instruments. The GCC is characterized by premium hospital investment, centralized public-sector procurement, medical tourism strategies, and demand for high-performance implants and infection-prevention technologies aligned with healthcare diversification initiatives.

The European Union is a critical regulatory and clinical validation environment where MDR compliance, post-market clinical follow-up, harmonized standards, and health technology assessment discipline influence product design and market access for bioactive coated devices. BRICS economies provide scale advantages through large patient populations, growing domestic medtech sectors, and government interest in reducing import dependence, although regulatory pathways, pricing controls, procurement rules, and local manufacturing requirements vary widely across members.

G7 countries remain central to advanced R&D, premium device adoption, reimbursement evidence, clinical guideline influence, and early adoption of AI-enabled quality and materials development. NATO-aligned healthcare systems often emphasize supply-chain resilience, trusted sourcing, cybersecurity for connected manufacturing, and continuity of critical medical technologies. Across these groups, success depends on localized regulatory strategy, clinical evidence, manufacturing reliability, and partnerships that address affordability without compromising coating performance or patient safety.

Key Country Insights for Bioactive Coating Device Adoption

The United States leads bioactive coating device adoption through advanced surgical utilization, strong hospital infection-control priorities, established pathways for cleared and approved medical devices, and demand for drug-eluting stents, antimicrobial catheters, orthopedic implants, and advanced wound care. Canada emphasizes quality, safety, public reimbursement discipline, and evidence-based procurement, while Mexico offers manufacturing advantages, nearshoring relevance, and growing domestic demand. Brazil is Latin America’s largest healthcare market and supports opportunities in orthopedics, dental implants, cardiovascular care, and wound management, though regulatory timelines, regional access differences, and pricing pressure require careful planning.

In Europe, the United Kingdom remains influential in clinical evaluation, health technology assessment, and infection-prevention policy; Germany is a major engineering, manufacturing, and orthopedic implant hub; France combines strong hospital purchasing with regulatory sophistication; Italy and Spain provide mature demand for dental, cardiovascular, orthopedic, and surgical device solutions; and Russia presents localized production and supply-chain considerations shaped by geopolitical constraints, import substitution efforts, and procurement complexity.

Across Asia-Pacific, China is scaling domestic medtech innovation, centralized procurement reform, and local production of advanced devices; India offers high-volume procedure growth and cost-sensitive adoption supported by expanding hospital infrastructure; Japan prioritizes precision, safety, aging-population care, and advanced biomaterials; Australia provides a rigorous but attractive environment for premium devices and clinical evidence generation; and South Korea combines advanced manufacturing, digital health readiness, and rapid adoption of high-value medical technologies.

Actionable Recommendations for Bioactive Coating Device Leaders

Industry leaders should prioritize clinically differentiated bioactive coatings that address measurable unmet needs, especially device-associated infections, thrombosis, poor osseointegration, inflammation, chronic wounds, and revision procedures. Commercial claims should be supported by robust in vitro testing, preclinical evidence, sterilization validation, biocompatibility data, chemical characterization, and, where appropriate, clinical or real-world outcomes.

Manufacturers should build regulatory strategy into early R&D by aligning coating chemistry, device classification, combination-product considerations, extractables and leachables testing, shelf-life expectations, and post-market surveillance obligations. Scalable process controls are essential because coating thickness, adhesion, porosity, drug-release kinetics, surface energy, particulate generation, and mechanical durability can directly affect safety and performance.

Executives should also pursue partnerships with hospitals, contract manufacturers, biomaterials laboratories, AI analytics providers, academic research centers, and regional distributors. Winning strategies will combine strong intellectual property, localized market access, cybersecurity-aware digital quality systems, supply-chain resilience, and value-based evidence that demonstrates reduced complications, improved device performance, and lower total cost of care.

Research Methodology

This executive summary is developed using a structured secondary-research framework aligned with established market intelligence standards. The analysis synthesizes publicly available and verifiable information from regulatory agencies, public-health bodies, standards organizations, peer-reviewed literature, clinical guidelines, patent activity, healthcare procurement signals, technology assessments, and regional policy developments.

The methodology emphasizes triangulation across demand drivers, technology trends, regulatory requirements, competitive positioning, manufacturing readiness, and regional adoption indicators. Insights are validated against known clinical burdens such as healthcare-associated infections, antimicrobial resistance, chronic disease prevalence, cardiovascular disease, musculoskeletal disorders, aging populations, and rising use of implantable and minimally invasive devices.

The research approach avoids unsupported market sizing claims and focuses on evidence-backed themes relevant to executive decision-making, including innovation pathways, coating performance requirements, compliance risk, adoption barriers, procurement dynamics, and commercial opportunities across regions, country clusters, and device applications.

Conclusion

The bioactive coating devices market is moving from niche surface engineering toward a mainstream medtech growth category. Rising infection-prevention needs, increased implant utilization, expanding minimally invasive procedures, antimicrobial resistance concerns, and demand for longer-lasting devices are strengthening the role of antimicrobial, drug-eluting, osteoconductive, anti-thrombogenic, hemocompatible, and regenerative coatings.

Future leadership will depend on the ability to prove clinical value, manufacture consistently, comply with evolving regulatory expectations, and tailor solutions to regional healthcare priorities. Companies that integrate biomaterials expertise, AI-enabled development, robust quality systems, scalable coating processes, and real-world evidence will be best positioned to compete in an environment where performance, safety, and cost-effectiveness increasingly determine adoption.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Bioactive Coating Devices Market, by Device Type
7.1. Introduction
7.2. Dressings
7.3. Implants
7.4. Scaffolds
7.5. Stents
8. Bioactive Coating Devices Market, by Coating Material
8.1. Introduction
8.2. Bioactive Glass
8.3. Chitosan
8.4. Collagen
8.5. Hydroxyapatite
8.6. Silver Nanoparticles
8.7. Titanium Dioxide
9. Bioactive Coating Devices Market, by Technology
9.1. Introduction
9.2. Chemical Vapor Deposition
9.3. Dip Coating
9.4. Electrophoretic Deposition
9.5. Laser Deposition
9.6. Plasma Spraying
9.7. Sol-Gel
9.8. Spin Coating
10. Bioactive Coating Devices Market, by Application
10.1. Introduction
10.2. Cardiovascular Stents
10.2.1. Bare Metal Stents
10.2.2. Bioresorbable Stents
10.2.3. Drug Eluting Stents
10.3. Dental Implants
10.3.1. Endosseous Implants
10.3.2. Subperiosteal Implants
10.4. Orthopedic Implants
10.4.1. Hip Implants
10.4.2. Knee Implants
10.4.3. Spinal Implants
10.5. Tissue Engineering Scaffolds
10.6. Wound Dressings
11. Bioactive Coating Devices Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Research Laboratories
12. Bioactive Coating Devices Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Bioactive Coating Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Bioactive Coating Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AST Products, Inc.
16.2. Biocoat Incorporated
16.3. BioInteractions Ltd.
16.4. Bruker Corporation
16.5. Carmeda AB
16.6. Harland Medical Systems, Inc.
16.7. Hexacath Company
16.8. Himed LLC
16.9. Hydromer, Inc.
16.10. implantcast GmbH
16.11. LipoCoat BV
16.12. OC Oerlikon Management AG
16.13. Panacol-Elosol GmbH
16.14. Picosun Oy by Applied Materials, Inc.
16.15. Royal DSM
16.16. Specialty Coating Systems Inc.
16.17. SurModics Inc.
16.18. Surmodics, Inc.
16.19. Tissue Regeneration Systems, Inc.
List of Figures
FIGURE 1. GLOBAL BIOACTIVE COATING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOACTIVE COATING DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOACTIVE COATING DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOACTIVE COATING DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOACTIVE COATING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BIOACTIVE COATING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOACTIVE COATING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DRESSINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DRESSINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DRESSINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SCAFFOLDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SCAFFOLDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SCAFFOLDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL BIOACTIVE GLASS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CHITOSAN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CHITOSAN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CHITOSAN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL COLLAGEN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL COLLAGEN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL COLLAGEN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL HYDROXYAPATITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL HYDROXYAPATITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HYDROXYAPATITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SILVER NANOPARTICLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SILVER NANOPARTICLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SILVER NANOPARTICLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL TITANIUM DIOXIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL TITANIUM DIOXIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL TITANIUM DIOXIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CHEMICAL VAPOR DEPOSITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CHEMICAL VAPOR DEPOSITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CHEMICAL VAPOR DEPOSITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DIP COATING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DIP COATING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DIP COATING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ELECTROPHORETIC DEPOSITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ELECTROPHORETIC DEPOSITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL ELECTROPHORETIC DEPOSITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL LASER DEPOSITION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LASER DEPOSITION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LASER DEPOSITION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PLASMA SPRAYING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PLASMA SPRAYING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL PLASMA SPRAYING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SOL-GEL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SOL-GEL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SOL-GEL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SPIN COATING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SPIN COATING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SPIN COATING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL BARE METAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL BARE METAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL BARE METAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL BIORESORBABLE STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL DENTAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOSSEOUS IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL SUBPERIOSTEAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ORTHOPEDIC IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL HIP IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HIP IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HIP IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL KNEE IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL KNEE IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL KNEE IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL SPINAL IMPLANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL TISSUE ENGINEERING SCAFFOLDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL TISSUE ENGINEERING SCAFFOLDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TISSUE ENGINEERING SCAFFOLDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL WOUND DRESSINGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL WOUND DRESSINGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL WOUND DRESSINGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 133. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 135. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 136. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 137. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 138. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 139. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 141. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 142. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 143. EUROPE BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 153. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 154. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 155. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 156. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 157. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 158. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 159. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 160. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 161. AFRICA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 165. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 166. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 168. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 169. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 170. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 171. ASEAN BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 172. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 174. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 175. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 177. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 178. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 179. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 180. GCC BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 190. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 191. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 192. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 193. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 195. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 196. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 197. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 198. BRICS BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 199. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 200. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 201. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 202. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 203. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 205. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 206. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 207. G7 BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 208. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 209. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 210. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 211. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 212. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 214. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 215. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 216. NATO BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 217. GLOBAL BIOACTIVE COATING DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 222. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 227. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 229. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 230. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 231. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 233. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 234. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 235. CANADA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 236. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 237. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 238. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 239. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 241. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 242. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 243. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 244. MEXICO BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 252. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 253. BRAZIL BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 262. UNITED KINGDOM BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 263. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 265. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 266. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 267. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 269. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 270. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 271. GERMANY BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 272. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 274. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 275. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 276. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 277. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 278. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 279. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 280. FRANCE BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 290. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 291. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 292. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 293. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 294. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 295. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 296. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 297. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 298. ITALY BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 299. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 300. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 301. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 302. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 303. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 305. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 306. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 307. SPAIN BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 308. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 309. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 310. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 311. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 313. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 314. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 315. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 316. CHINA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 317. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 319. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 320. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 321. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 323. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 324. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 325. INDIA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 326. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 327. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 328. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 329. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 332. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 333. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 334. JAPAN BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 335. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 337. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 338. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 339. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 340. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY CARDIOVASCULAR STENTS, 2017-2032 (USD MILLION)
TABLE 341. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY DENTAL IMPLANTS, 2017-2032 (USD MILLION)
TABLE 342. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY ORTHOPEDIC IMPLANTS, 2017-2032 (USD MILLION)
TABLE 343. AUSTRALIA BIOACTIVE COATING DEVICES MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 344. SOUTH KOREA BIOACTIVE COATING DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. SOUTH KOREA BIOACTIVE COATING DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 346. SOUTH KOREA BIOACTIVE COATING DEVICES MARKET SIZE, BY COATING MATERIAL, 2017-2032 (USD MILLION)
TABLE 347. SOUTH KOREA BIOACTIVE COATING DEVICES MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 348. SOUTH KOREA BIOACTIVE COATING DEVI

Companies Mentioned

  • AST Products, Inc.
  • Biocoat Incorporated
  • BioInteractions Ltd.
  • Bruker Corporation
  • Carmeda AB
  • Harland Medical Systems, Inc.
  • Hexacath Company
  • Himed LLC
  • Hydromer, Inc.
  • implantcast GmbH
  • LipoCoat BV
  • OC Oerlikon Management AG
  • Panacol-Elosol GmbH
  • Picosun Oy by Applied Materials, Inc.
  • Royal DSM
  • Specialty Coating Systems Inc.
  • SurModics Inc.
  • Surmodics, Inc.
  • Tissue Regeneration Systems, Inc.

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2.1 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.47 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned19

Related Topics

Related Reports

Bioactive Materials Market - Global Forecast 2026-2032 - Product Image

Bioactive Materials Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Bioactive Glass Market - Global Forecast 2026-2032 - Product Image

Bioactive Glass Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Medical Anti-Thrombotic Coating Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Medical Anti-Thrombotic Coating Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Biocompatible Coatings - Global Strategic Business Report - Product Image

Biocompatible Coatings - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From
Bioactive Materials - Global Strategic Business Report - Product Image

Bioactive Materials - Global Strategic Business Report

  • Report
  • 234 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.